North America Nucleic Acid Testing Market Opportunities in the US, Canada, Mexico

North America Nucleic Acid Testing Market Opportunities in the US, Canada, Mexico

This new 3-country report is available by country, market segment, section, or individual test.

The report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years. The report is available by section, and can be customized to specific information needs and budget.

Highlights

Supplier sales and market shares in major countries

Five-year test volume and sales forecasts

Strategic profiles of market players and start-up firms developing innovative technologies and products

Emerging technologies

Review of molecular diagnostic analyzers

Specific product and business opportunities for instrument and consumable suppliers

Rationale

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Country Analyses

Canada, Mexico, USA

Market Segmentation Analysis

Sales and market shares of key suppliers of molecular diagnostic reagent kits and components in major markets.

Five-year test volume and sales forecasts for major applications, including:

Infectious Diseases

Forensic Testing

Cancer

Paternity Testing/HLA Typing

Genetic Diseases

Others

Five-year test volume and sales projections for over 30 NAT assays.

A comprehensive analysis of the sequencing market, by country and laboratory segment, including:

Industrial

Academic

Government

Commercial

Market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and suppliers in major countries.

Product/Technology Review

Comparison of leading molecular diagnostic analyzers marketed by Abbott, Beckman Coulter, BD, Bio-Rad, Gen-Probe, Roche, Tecan and other suppliers.

Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods.

Universities and research centers developing new molecular diagnostic technologies and products.

Competitive Assessments

Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.

Companies developing and marketing molecular diagnostics products, by test and application.

Opportunities and Strategic Recommendations

Specific new product development opportunities with potentially significant market appeal during the next five years.

Design criteria for new products.

Alternative market penetration strategies.

Potential market entry barriers and risks.

Business planning issues and concerns.

Competitive Assessments

Abbott
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher/Cepheid
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Decode Genetics
Diasorin
Eiken Chemical
Elitech Group
Enzo Biochem
Exact Sciences
Fujirebio
Grifols
Hologic/Gen-Probe
Illumina
LabCorp/Sequenom
Leica Biosystems/Kreatech
Li-Cor Biosciences
Myriad Genetics
Proteome Sciences
Qiagen
Quest Diagnostics
QuidelOrtho
Roche
Shimadzu
Siemens Healthineers
Takara Bio
Tecan Group
Thermo Fisher

I. Introduction
II. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Computers, Software and Automation
D. Auxiliary Products
III. Design Criteria for Decentralized Testing Products
IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
V. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. Market and Technology Review
A. DNA Sequencing
1. Introduction
2. Sequencing Methods
3. Autoradiography
4. The Human Genome Project
5. Sequencing Automation
6. Image Scanners
7. Fluorescent Detection
8. Gene Profiling
9. Gene Expression
10. Polymorphism Screening
11. Protein Interaction Networks

B. DNA and RNA Probe Technologies
1. Basic Principles
2. Probe Preparation
3. The DNA Probe Test
4. Test Formats
5. Labeling Techniques
6. Amplification Methods
C. Detection Technologies
1. Radioactive Methods
2. Non-Isotopic Methods
D. Instrumentation
Review of latest analyzers from Abbott, Beckm an Coulter/Danaher, Becton Dickinson, bioMerieux,
Bio-Rad, Cepheid, Hologic, Qiagen, Roche, Siemens Healthineers, and others.
E. Biochips: Genosensors, Microarrays, Labs-on-the-Chip
- Liquid Transportation and Mixing
- Separation
- Reaction
- Detection
F. Pharmacogenomics
G. Major Applications
1. Microbiology/Infectious
Diseases
a. Overview
b. Major Infectious
Diseases
- AIDS/HIV
- Adenovirus
- Aeromonads
- Anthrax/Bacillus Anthracis
- Arboviruses
- Babesiosis
- Bacillary Epithelioid Angiomatosis (BEA), other Bartonella (Rochalimaea)
- Blastocystis Hominis
- Brucella
- Campylobacter
- Candida
- Chagas Disease

- Chancroid
- Chlamydia
- Clostridium Difficile
- Coronaviruses
- Coxsackieviruses
- Creutzfeldt-Jakobs Disease
- Cryptosporidium Parvum
- Cyclospora Cayetanensis
- Cytomegalovirus
- Ebola Virus
- E. Coli
- EchoVirus
- Encephalitis
- Enteroviruses
- Epstein-Barr Virus
- Giardia Lamblia
- Gonorrhea
- Granuloma Inguinale
- Hantavirus
- Helicobacter Pylori
- Hepatitis
- Herpes Simplex Virus
- Human Herpes Virus-6 (HHV-6)
- Influenza Viruses
- Legionella
- Lyme Disease
- Lymphogranuloma Venereum (LGV)
- Malaria
- Measles (Rubeo la)
- Meningitis
- Microsporidium
- Mononucleosis
- Mumps
- Mycoplasma
- Papillomaviruses
- Parvovirus B19
- Pneumonia
- Polyomaviruses
- Pseudomonas Aeruginosa
- Rabies
- Respiratory Syncytial Virus (RSV)
- Rhinoviruses
- Rotavirus
- Rubella
- Salmonellosis
- Septicemia
- Shigellosis
- Staphylococcus Aureus
- Streptococci

- Syphilis
- Toxoplasmosis
- Trichomonas Vaginalis
- Tuberculosis
- Vibrio
- West Nile Virus
- Yersina
- West Nile Virus
- Yersina
2. Cancer Testing
a. Overview
b. Major Cancer Types
- Prostate
- Lung
- Colon and Rectum
- Breast
- Skin
- Uterine
- Leukemia
- Oral
c. Oncogenes
The report provides review of both current and emerging oncogenes, including:
- Abl/abl-bcr
- AIB1
- BCL-2
- BRCA1
- CD44
- C-fos
- C-myb
- C-myc
- CYP17
- Erb-B
- HPC1
- N-myc
- P40
- P51
- P53
- PIK3CA
- PTI-1
- Ras
- Reg
- Sis
- Src

3. Genetic Diseases
a. Overview
b. Nucleic Acid Amplification
c. Chromosome Imaging
d. Genomics Technologies
e. Proteomics Technologies
f. Current Pharmacogenomic Tests
g. Future Pharmacogenomic Testing
h. Major Diseases
- Achondroplasia
- Autosomal Dominant Polycystic Kidney Disease
- Cancer
- Cosmetogenomics
- Cystic Fibrosis
- Downs Syndrome
- Duchenne and Becker Muscular Dystrophy
- Factor V (Leiden)
- Factor IX Deficiency
- Fragile X Syndrome
- Heart Disease
- Hemochomatosis
- Hemophilia
- Huntingtons Disease
- Maternal-Fetal Incompatibility
- Multiple Endocrine Neoplasia
- Phenylketonuria (PKU)
- Polycystic Kidney Disease (PKD)
- Prenatal Screening
- Retinitis Pigmentosa
- Retinoblastoma
- Sickle Cell Anemia
- Spinal Muscular Atrophy
- Vitamin B12 Metabolism
i. Social Issues and Concerns
4. Forensic Testing
a. Overview
b. Multilocus and Single Locus Probes
c. DNA Profile Data Banks
d. Judicial Implementation
e. Major Crime Categories
f. Factors Contributing to the DNA Probe Market Expansion
- Technology Availability
- Use of Hair as Evidence
g. Wildlife Forensics
5. Paternity Testing/HLA Typing

6. Other Applications
a. Disease Susceptibility Testing
b. Cardiovascular Diseases
c. Diabetes
d. Alzheimers Disease
e. Periodontal Disease
f. Plasma Purification
g. Organ Transplantation
h. Water Contamination
i. Other
H. Competing/complementing
1. Monoclonal Antibodies/Immunoassays
2. RNA Probes
3. Two-Dimensional Electrophoresis
4. Flow Cytometry
VII. 3-Country Analyses: Volume and Sales Forecasts--Infectious Diseases, Genetic
Diseases, Cancer, Forensic and Paternity Testing
VIII. Competitive Assessments
The report provides strategic assessments of over 40 leading molecular diagnostics market players and
start-up companies with innovative technologies and products, including:
Abbott, Agilent Technologies, Beckman Coulter/Danaher, Becton Dickinson, bioMerieux, Bio-Rad,
Cepheid, DiaSorin, Eiken Chemical, Enzo, Fujirebio, Grifols, Hologic, Illumina, LabCorp/Sequenom, Leica
Biosystems, Myriad Genetics, Ortho-Clinical Diagnostics, Qiagen, Quest Diagnostics, Quidel, Roche,
Shimadzu, Siemens Healthineers, Sierra Molecular, Takara Bio, Tecan Group, Thermo Fisher, Wako and
others.
IX. Appendix: Major Universities and Research Centers Developing Innovative
Molecular Diagnostic Technologies and Products

List Of Tables

Canada
Molecular Diagnostics Test Volume and Sales Forecasts by Application
Canada
Molecular Diagnostics Test Volume Forecasts by Application
Canada
Major Infectious Disease Test Volume Forecasts by Assay
Canada
Molecular Diagnostics Market Forecasts by Application
Canada
Major Infectious Disease Diagnostics Market Forecasts by Assay
Mexico
Molecular Diagnostics Test Volume and Sales Forecasts by Application
Mexico
Molecular Diagnostics Test Volume Forecasts by Application
Mexico
Major Infectious Disease Test Volume Forecasts by Assay
Mexico
Molecular Diagnostics Market Forecasts by Application
Mexico
Major Infectious Disease Diagnostics Market Forecasts by Assay
U.S.A.
Molecular Diagnostics Test Volume and Sales by Major Application
U.S.A.
Laboratories Performing DNA Sequencing by Market Segment
U.S.A.
Echovirus Testing Market Estimated Sales by Major Supplier
U.S.A.
Enterovirus Testing Market Estimated Sales by Major Supplier
U.S.A.
EBV Testing Market Estimated Sales by Major Supplier

U.S.A.
Gonorrhea Testing Market Estimated Sales by Major Supplier
U.S.A.
Hepatitis Testing Market Estimated Sales by Major Supplier
U.S.A.
Hepatitis C Testing Market Estimated Sales by Major Supplier
U.S.A.
HIV/Hepatitis Blood Screening NAT
Market Reagent Sales by Major Supplier
U.S.A.
Herpes Testing Market Estimated Sales by Major Supplier
U.S.A.
Influenza Testing Market Estimated Sales by Major Supplier
U.S.A.
Meningitis Testing Market Estimated Sales by Major Supplier
U.S.A.
Mycoplasma Testing Market Estimated Sales by Major Supplier
U.S.A.
Pneumonia Testing Market Estimated Sales by Major Supplier
U.S.A.
Rabies Testing Market Estimated Sales by Major Supplier
U.S.A.
RSV Testing Market Estimated Sales by Major Supplier
U.S.A.
Salmonella Testing Market Estimated Sales by Major Supplier
U.S.A.
Shigella Testing Market Estimated Sales by Major Supplier
U.S.A.
West Nile Virus Nat Market Reagent Sales by Major Supplier
Major Companies Developing or Marketing AIDS Molecular
Diagnostic and Other Direct Identification Tests

Major Companies Developing or Marketing Adenovirus
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Bartonella
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Campylobacter
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Candida
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Chlamydia
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Clostridium
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Coronavirus
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Cryptosporidium
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing CMV Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Echovirus Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Enterovirus Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular
Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Giardia
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Gonorrhea
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Hantavirus
Molecular Diagnostic and Other Direct Identification Tests

Major Companies Developing or Marketing Helicobacter
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Hepatitis
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Herpes
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Influenza
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Legionella
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Lyme
Disease Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Measles
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Meningitis
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mononucleosis
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mumps
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mycoplasma
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Pneumonia
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing RSV
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Rotavirus
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Rubella
Molecular Diagnostic and Other Direct Identification Tests

Major Companies Developing or Marketing Salmonella
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Septicemia
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Shigella
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Streptococci
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Syphilis
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Toxoplasmosis
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Trichomonas
Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Tuberculosis
Molecular Diagnostic and Other Direct Identification Tests
Oncogenes Potential Application in Cancer Diagnosis
Major Companies Developing or Marketing Cancer
Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular
Diagnostic Tests for Genetic Diseases

Fill The Form For Sample Request

Full Name*

Business Email *

E-mail

Country *

Select Country Albania Algeria Afghanistan Angola Argentina Armenia Aruba Australia Austria Azerbaijan Andorra Anguilla Bahrain Bangladesh Barbados Belarus Belgium Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Bosnia Cambodia Cameroon Central African Republic Chad Chile China Colombia Comoros Congo (Brazzaville) Cook Islands Costa Rica Cote d Ivoire Croatia Cuba Cyprus Czech Republic Cayman Islands Denmark Djibouti Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Gibraltar Greece Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Herzegovina Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Korea Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Lithuania Luxembourg Liechtenstein Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Middle East & North Africa (MENA) Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria North Korea Norway Oman Pakistan Palau Palestinian Territories Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Palestine Qatar Romania Russia Rwanda Samoa Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Korea Spain Sri Lanka Saint Kitts and Nevis Saint Vincent and the Grenadines Sudan Suriname Swaziland Sweden Switzerland Syria Scotland San Marino Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States of America Uruguay Uzbekistan Uraguay Vanuatu Venezuela Vietnam Virgin Islands Yemen Zambia Zimbabwe Canada Grenada Cape Verde Belize Curacao Republic of Srpska Antigua and Barbuda Saint Lucia Falkland Islands Faroe Islands Federated States of Micronesia Guadeloupe Martinique Montserrat Niue

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available